These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 25164760)

  • 1. Design, synthesis and evaluation of Ospemifene analogs as anti-breast cancer agents.
    Kaur G; Mahajan MP; Pandey MK; Singh P; Ramisetti SR; Sharma AK
    Eur J Med Chem; 2014 Oct; 86():211-8. PubMed ID: 25164760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, and anti-breast cancer evaluation of new triarylethylene analogs bearing short alkyl- and polar amino-/amido-ethyl chains.
    Kaur G; Mahajan MP; Pandey MK; Singh P; Ramisetti SR; Sharma AK
    Bioorg Med Chem Lett; 2016 Apr; 26(8):1963-9. PubMed ID: 26972118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, biological evaluation and molecular docking studies of novel 3-aryl-4-anilino-2H-chromen-2-one derivatives targeting ERα as anti-breast cancer agents.
    Luo G; Chen M; Lyu W; Zhao R; Xu Q; You Q; Xiang H
    Bioorg Med Chem Lett; 2017 Jun; 27(12):2668-2673. PubMed ID: 28460819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticancer phytochemical analogs 37: synthesis, characterization, molecular docking and cytotoxicity of novel plumbagin hydrazones against breast cancer cells.
    Dandawate P; Ahmad A; Deshpande J; Swamy KV; Khan EM; Khetmalas M; Padhye S; Sarkar F
    Bioorg Med Chem Lett; 2014 Jul; 24(13):2900-4. PubMed ID: 24835626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective estrogen receptor modulators in the ruthenocene series. Synthesis and biological behavior.
    Pigeon P; Top S; Vessières A; Huché M; Hillard EA; Salomon E; Jaouen G
    J Med Chem; 2005 Apr; 48(8):2814-21. PubMed ID: 15828819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and synthesis of novel flexible ester-containing analogs of tamoxifen and their evaluation as anticancer agents.
    Elghazawy NH; Engel M; Hartmann RW; Hamed MM; Ahmed NS; Abadi AH
    Future Med Chem; 2016; 8(3):249-56. PubMed ID: 26898104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytostatic and cytotoxic action of Z-1, 1-dichloro-2,3-diphenylcyclopropane in three human breast cancer cell lines.
    ter Haar E; Day BW
    Anticancer Res; 1996; 16(3A):1107-15. PubMed ID: 8702221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and bioevaluation of novel 6-(4-Hydroxypiperidino)naphthalen-2-ol-based potential Selective Estrogen Receptor Modulators for breast cancer.
    Jha A; Yadav Y; Naidu AB; Rao VK; Kumar A; Parmar VS; MacDonald WJ; Too CK; Balzarini J; Barden CJ; Cameron TS
    Eur J Med Chem; 2015 Mar; 92():103-14. PubMed ID: 25544690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiestrogenic and DNA damaging effects induced by tamoxifen and toremifene metabolites.
    Liu X; Pisha E; Tonetti DA; Yao D; Li Y; Yao J; Burdette JE; Bolton JL
    Chem Res Toxicol; 2003 Jul; 16(7):832-7. PubMed ID: 12870885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ligand-induced regulation of ERalpha and ERbeta is indicative of human breast cancer cell proliferation.
    Power KA; Thompson LU
    Breast Cancer Res Treat; 2003 Oct; 81(3):209-21. PubMed ID: 14620916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of constrained tamoxifen mimics and their antiproliferative properties against breast cancer cells.
    Archana S; Geesala R; Rao NB; Satpati S; Puroshottam G; Panasa A; Dixit A; Das A; Srivastava AK
    Bioorg Med Chem Lett; 2015 Feb; 25(3):680-4. PubMed ID: 25529734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
    Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
    Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Selective Estrogen Receptor Ligand Conjugates Incorporating Endoxifen-Combretastatin and Cyclofenil-Combretastatin Hybrid Scaffolds: Synthesis and Biochemical Evaluation.
    Kelly PM; Keely NO; Bright SA; Yassin B; Ana G; Fayne D; Zisterer DM; Meegan MJ
    Molecules; 2017 Aug; 22(9):. PubMed ID: 28858267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An estrogen receptor targeted ruthenium complex as a two-photon photodynamic therapy agent for breast cancer cells.
    Zhao X; Li M; Sun W; Fan J; Du J; Peng X
    Chem Commun (Camb); 2018 Jun; 54(51):7038-7041. PubMed ID: 29873358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of 2,2-dimethyl-chroman-based stereochemically flexible and constrained anti-breast cancer agents.
    Nainawat KS; Gupta K; Gupta N; Singh R; Mishra D; Nirwan A; Verma M; Singh A; Vasudev PG; Khan F; Mishra DP; Gupta A
    Bioorg Med Chem Lett; 2024 Aug; 108():129789. PubMed ID: 38729318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-tumor activity of novel biisoquinoline derivatives against breast cancers.
    Jaiswal AS; Hirsch-Weil D; Proulx ER; Hong S; Narayan S
    Bioorg Med Chem Lett; 2014 Oct; 24(20):4850-3. PubMed ID: 25240616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and synthesis of novel benzothiophene analogs as selective estrogen receptor covalent antagonists against breast cancer.
    Bai C; Ren S; Wu S; Zhu M; Luo G; Xiang H
    Eur J Med Chem; 2021 Oct; 221():113543. PubMed ID: 34022716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
    Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
    Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of targeted dibenzo[b,f]thiepines and dibenzo[b,f]oxepines as potential lead molecules with promising anti-breast cancer activity.
    Ansari MI; Hussain MK; Arun A; Chakravarti B; Konwar R; Hajela K
    Eur J Med Chem; 2015 Jun; 99():113-24. PubMed ID: 26067208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and cancer cell growth inhibitory activity of icaritin derivatives.
    Wang C; Wu P; Shi JF; Jiang ZH; Wei XY
    Eur J Med Chem; 2015 Jul; 100():139-50. PubMed ID: 26079090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.